![](/img/cover-not-exists.png)
Randomized phase II trial of maintenance autologous tumor cell vaccine (FANG™) following clinical complete response (cCR) in stage III/IV ovarian cancer: Preliminary results
Oh, J., Barve, M., Grosen, E.A., Fine, B.A., Heffernan, T.P., Matthews, C.M., Stringer, C.A., Koon, E.C., Goodman, H.M., Fleming, E.L., DeMars, L.R., Bergman, M.S., Senzer, N., Nemunaitis, J.Volume:
137
Language:
english
Journal:
Gynecologic Oncology
DOI:
10.1016/j.ygyno.2015.01.003
Date:
April, 2015
File:
PDF, 390 KB
english, 2015